159 related articles for article (PubMed ID: 33079257)
1. Organoid culture system for patient-derived lung metastatic osteosarcoma.
He A; Huang Y; Cheng W; Zhang D; He W; Bai Y; Gu C; Ma Z; He Z; Si G; Chen B; Breault DT; Dong M; Xiang D
Med Oncol; 2020 Oct; 37(11):105. PubMed ID: 33079257
[TBL] [Abstract][Full Text] [Related]
2. Trabectedin Overrides Osteosarcoma Differentiative Block and Reprograms the Tumor Immune Environment Enabling Effective Combination with Immune Checkpoint Inhibitors.
Ratti C; Botti L; Cancila V; Galvan S; Torselli I; Garofalo C; Manara MC; Bongiovanni L; Valenti CF; Burocchi A; Parenza M; Cappetti B; Sangaletti S; Tripodo C; Scotlandi K; Colombo MP; Chiodoni C
Clin Cancer Res; 2017 Sep; 23(17):5149-5161. PubMed ID: 28600479
[No Abstract] [Full Text] [Related]
3. The Fas/FasL Signaling Pathway: Its Role in the Metastatic Process and as a Target for Treating Osteosarcoma Lung Metastases.
Koshkina N; Yang Y; Kleinerman ES
Adv Exp Med Biol; 2020; 1258():177-187. PubMed ID: 32767242
[TBL] [Abstract][Full Text] [Related]
4. Practical Considerations in Studying Metastatic Lung Colonization in Osteosarcoma Using the Pulmonary Metastasis Assay.
Lizardo MM; Sorensen PH
J Vis Exp; 2018 Mar; (133):. PubMed ID: 29578500
[TBL] [Abstract][Full Text] [Related]
5. Organoid Cultures as Preclinical Models of Non-Small Cell Lung Cancer.
Shi R; Radulovich N; Ng C; Liu N; Notsuda H; Cabanero M; Martins-Filho SN; Raghavan V; Li Q; Mer AS; Rosen JC; Li M; Wang YH; Tamblyn L; Pham NA; Haibe-Kains B; Liu G; Moghal N; Tsao MS
Clin Cancer Res; 2020 Mar; 26(5):1162-1174. PubMed ID: 31694835
[TBL] [Abstract][Full Text] [Related]
6. Tegavivint and the β-Catenin/ALDH Axis in Chemotherapy-Resistant and Metastatic Osteosarcoma.
Nomura M; Rainusso N; Lee YC; Dawson B; Coarfa C; Han R; Larson JL; Shuck R; Kurenbekova L; Yustein JT
J Natl Cancer Inst; 2019 Nov; 111(11):1216-1227. PubMed ID: 30793158
[TBL] [Abstract][Full Text] [Related]
7. Efficient use of patient-derived organoids as a preclinical model for gynecologic tumors.
Maru Y; Tanaka N; Itami M; Hippo Y
Gynecol Oncol; 2019 Jul; 154(1):189-198. PubMed ID: 31101504
[TBL] [Abstract][Full Text] [Related]
8. From genomics to metabolomics: emerging metastatic biomarkers in osteosarcoma.
Dean DC; Shen S; Hornicek FJ; Duan Z
Cancer Metastasis Rev; 2018 Dec; 37(4):719-731. PubMed ID: 30167827
[TBL] [Abstract][Full Text] [Related]
9. Apatinib inhibits migration and invasion as well as PD-L1 expression in osteosarcoma by targeting STAT3.
Zheng B; Ren T; Huang Y; Guo W
Biochem Biophys Res Commun; 2018 Jan; 495(2):1695-1701. PubMed ID: 29225166
[TBL] [Abstract][Full Text] [Related]
10. Strong expression of paired-like homeodomain transcription factor 1 (PITX1) is associated with a favorable outcome in human osteosarcoma.
Kong G; Liu Z; Wu K; Zhang Y; Deng Z; Feng W; Chen S; Wang H
Tumour Biol; 2015 Sep; 36(10):7735-41. PubMed ID: 25936343
[TBL] [Abstract][Full Text] [Related]
11. Fine-needle aspiration biopsy of skeletal versus extraskeletal osteosarcoma.
Nicol KK; Ward WG; Savage PD; Kilpatrick SE
Cancer; 1998 Jun; 84(3):176-85. PubMed ID: 9678733
[TBL] [Abstract][Full Text] [Related]
12. Metastatic osteosarcoma.
Daw NC; Billups CA; Rodriguez-Galindo C; McCarville MB; Rao BN; Cain AM; Jenkins JJ; Neel MD; Meyer WH
Cancer; 2006 Jan; 106(2):403-12. PubMed ID: 16353204
[TBL] [Abstract][Full Text] [Related]
13. Zoledronic acid protects against osteosarcoma-induced bone destruction but lacks efficacy against pulmonary metastases in a syngeneic rat model.
Labrinidis A; Hay S; Liapis V; Findlay DM; Evdokiou A
Int J Cancer; 2010 Jul; 127(2):345-54. PubMed ID: 19924813
[TBL] [Abstract][Full Text] [Related]
14. Genetic and clonal dissection of osteosarcoma progression and lung metastasis.
Xu H; Zhu X; Bao H; Wh Shek T; Huang Z; Wang Y; Wu X; Wu Y; Chang Z; Wu S; Tang Q; Zhang H; Han A; Mc Cheung K; Zou C; Yau R; Ho WY; Huang G; Batalha S; Lu J; Song G; Kang Y; Shao YW; Lam YL; Shen J; Wang J
Int J Cancer; 2018 Sep; 143(5):1134-1142. PubMed ID: 29569716
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant chemotherapy for osteosarcoma of the extremities with synchronous lung metastases: treatment with cisplatin, adriamycin and high dose of methotrexate and ifosfamide.
Bacci G; Briccoli A; Ferrari S; Saeter G; Donati D; Longhi A; Manfrini M; Bertoni F; Rimondini S; Monti C; Forni C
Oncol Rep; 2000; 7(2):339-46. PubMed ID: 10671683
[TBL] [Abstract][Full Text] [Related]
16. Loss of osteoclasts contributes to development of osteosarcoma pulmonary metastases.
Endo-Munoz L; Cumming A; Rickwood D; Wilson D; Cueva C; Ng C; Strutton G; Cassady AI; Evdokiou A; Sommerville S; Dickinson I; Guminski A; Saunders NA
Cancer Res; 2010 Sep; 70(18):7063-72. PubMed ID: 20823153
[TBL] [Abstract][Full Text] [Related]
17. Fascin-1 enhances experimental osteosarcoma tumor formation and metastasis and is related to poor patient outcome.
Arlt MJ; Kuzmanov A; Snedeker JG; Fuchs B; Silvan U; Sabile AA
BMC Cancer; 2019 Jan; 19(1):83. PubMed ID: 30654764
[TBL] [Abstract][Full Text] [Related]
18. Mesenchymal stromal cells from primary osteosarcoma are non-malignant and strikingly similar to their bone marrow counterparts.
Brune JC; Tormin A; Johansson MC; Rissler P; Brosjö O; Löfvenberg R; von Steyern FV; Mertens F; Rydholm A; Scheding S
Int J Cancer; 2011 Jul; 129(2):319-30. PubMed ID: 20878957
[TBL] [Abstract][Full Text] [Related]
19. Outcomes of Adolescent and Adult Patients with Lung Metastatic Osteosarcoma and Comparison of Synchronous and Metachronous Lung Metastatic Groups.
Gok Durnali A; Paksoy Turkoz F; Ardic Yukruk F; Tokluoglu S; Yazici OK; Demirci A; Bal O; Gundogdu Buyukbas S; Esbah O; Oksuzoglu B; Alkis N
PLoS One; 2016; 11(5):e0152621. PubMed ID: 27167624
[TBL] [Abstract][Full Text] [Related]
20. Lung cells support osteosarcoma cell migration and survival.
Yu S; Fourman MS; Mahjoub A; Mandell JB; Crasto JA; Greco NG; Weiss KR
BMC Cancer; 2017 Jan; 17(1):78. PubMed ID: 28122543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
